EP1749531
Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.8.2005EP published:
22.7.2015EP application number:
05016875.6
EPO information:
European Patent Register
Max expiry date:
2.8.2025
Title:
Use of an oral suspension comprising megestrol acetate for the treatment of bronchial asthma
Timeline
Today
3.8.2005EP application
22.7.2015EP Publication
Owner
Name:
Par Pharmaceutical, Inc.Address:
300 Tice Boulevard, 07677, Woodcliff Lake, NJ, US
Inventor
Name:
Anker, StefanAddress:
Berlin, DE
Name:
Springer, JochenAddress:
Falkensee, DE
Classification
Categories:
A61K 31/57, A61P 11/06, A61K 45/06, A61K 9/10, A61K 9/00